Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Ammann, EM"'
Publikováno v:
In Value in Health May 2018 21 Supplement 1:S245-S245
Publikováno v:
In Value in Health May 2018 21 Supplement 1:S70-S70
Publikováno v:
In Value in Health October-November 2017 20(9):A411-A411
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Durie BGM; Cedars-Sinai Outpatient Cancer Center, 8700 Beverly Blvd, Los Angeles, CA, 90048, USA. bdurie@myeloma.org., Kumar SK; Department of Hematology, Mayo Clinic Rochester, Rochester, MN, USA., Ammann EM; Janssen Global Market Access, Raritan, NJ, USA., Fu AZ; Janssen Scientific Affairs, Horsham, PA, USA.; Georgetown University Medical Center, Washington, DC, USA., Kaila S; Janssen Scientific Affairs, Horsham, PA, USA., Lam A; Janssen Global Market Access, Raritan, NJ, USA., Usmani SZ; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Facon T; University of Lille, CHU Lille, Service des Maladies du Sang, Lille, France.
Publikováno v:
Advances in therapy [Adv Ther] 2024 May; Vol. 41 (5), pp. 1923-1937. Date of Electronic Publication: 2024 Mar 18.
Autor:
Mellqvist UH; Section of Hematology and Coagulation, Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden., Cai Q; Janssen Global Services, Titusville, New Jersey, USA., Hester LL; Janssen Research & Development, Horsham, Pennsylvania, USA., Grövdal M; Janssen-Cilag, Solna, Sweden., Börsum J; SDS Life Science, Stockholm, Sweden., Rahman I; SDS Life Science, Stockholm, Sweden., Ammann EM; Janssen Global Services, Raritan, New Jersey, USA., Hansson M; Department of Hematology, Sahlgrenska Academy, Göteborg University and Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Hematology, Skåne University Hospital, Lund, Sweden.
Publikováno v:
European journal of haematology [Eur J Haematol] 2023 Nov; Vol. 111 (5), pp. 697-705. Date of Electronic Publication: 2023 Aug 02.
Autor:
Fonseca R; Mayo Clinic, Phoenix, AZ. Electronic address: fonseca.rafael@mayo.edu., Tran D; EVERSANA(TM), Burlington, Ontario, Canada., Laidlaw A; EVERSANA(TM), Burlington, Ontario, Canada., Rosta E; EVERSANA(TM), Burlington, Ontario, Canada., Rai M; EVERSANA(TM), Burlington, Ontario, Canada., Duran J; Janssen Global Medical Affairs, Raritan, NJ., Ammann EM; Janssen Global Services, LLC, Raritan, NJ.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2023 Jun; Vol. 23 (6), pp. 426-437.e11. Date of Electronic Publication: 2023 Mar 18.
Autor:
Ammann EM; Janssen Research & Development, LLC, Raritan, NJ, USA., O'Brien ES; Janssen Global Services, LLC, Horsham, PA, USA., Milentijevic D; Janssen Scientific Affairs, LLC, Titusville, NJ, USA., Kharat AA; Janssen Scientific Affairs, LLC, Titusville, NJ, USA., Talbot DA; Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland., Canovatchel W; Janssen Global Services, LLC, Raritan, NJ, USA., Haskell L; Janssen Research & Development, LLC, Raritan, NJ, USA., Andrawis NS; Manassas Clinical Research Center, Manassas, VA, USA.
Publikováno v:
Heliyon [Heliyon] 2023 Jan 25; Vol. 9 (2), pp. e13258. Date of Electronic Publication: 2023 Jan 25 (Print Publication: 2023).
Autor:
Huntington SF; Yale School of Medicine, New Haven, CT, USA., Ingham MP; Janssen Scientific Affairs, Titusville, NJ, USA., Okonkwo L; Janssen Research & Development, Raritan, NJ, USA., Singh A; Mu Sigma, Bangalore, India., Wang R; Janssen Scientific Affairs, Titusville, NJ, USA.; Harvard T.H. Chan School of Public Health, Boston, MA, USA., Ammann EM; Janssen Research & Development, Raritan, NJ, USA.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2022 May; Vol. 63 (5), pp. 1180-1190. Date of Electronic Publication: 2021 Dec 16.
Autor:
Ammann EM; College of Public Health, University of Iowa, 145 North Riverside Drive, CPHB S441A, Iowa City, IA, 52242, USA.; Johnson & Johnson, Titusville, NJ, USA., Chrischilles EA; College of Public Health, University of Iowa, 145 North Riverside Drive, CPHB S441A, Iowa City, IA, 52242, USA. e-chrischilles@uiowa.edu., Carnahan RM; College of Public Health, University of Iowa, 145 North Riverside Drive, CPHB S441A, Iowa City, IA, 52242, USA., Fireman B; Kaiser Permanente Northern California, Oakland, CA, USA., Fuller CC; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA., Schweizer ML; College of Public Health, University of Iowa, 145 North Riverside Drive, CPHB S441A, Iowa City, IA, 52242, USA., Garcia C; College of Public Health, University of Iowa, 145 North Riverside Drive, CPHB S441A, Iowa City, IA, 52242, USA., Pimentel M; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA., Leonard CE; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Baker MA; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA., Cuker A; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Leira EC; College of Public Health, University of Iowa, 145 North Riverside Drive, CPHB S441A, Iowa City, IA, 52242, USA.; Division of Cerebrovascular Diseases, Department of Neurology, University of Iowa Carver College of Medicine, Iowa City, IA, USA., Robinson JG; College of Public Health, University of Iowa, 145 North Riverside Drive, CPHB S441A, Iowa City, IA, 52242, USA., Winiecki SK; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.; Center for Drug Evaluation and Research at FDA, Silver Spring, USA.
Publikováno v:
Journal of thrombosis and thrombolysis [J Thromb Thrombolysis] 2022 Feb; Vol. 53 (2), pp. 264-272. Date of Electronic Publication: 2021 Nov 24.